| human | Q5 |
| P496 | ORCID iD | 0000-0003-1610-4114 |
| P3829 | Publons author ID | 1378025 |
| P1053 | ResearcherID | F-3313-2016 |
| P1153 | Scopus author ID | 8953968300 |
| P108 | employer | Harvard Medical School | Q49121 |
| Massachusetts General Hospital | Q126412 | ||
| University of Cádiz | Q2000065 | ||
| P735 | given name | Monica | Q14013933 |
| Monica | Q14013933 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q33291163 | Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy |
| Q43158595 | Altered NCAM expression associated with the cholinergic system in Alzheimer's disease. |
| Q50422438 | Altered plasma-type gelsolin and amyloid-β in neonates with hypoxic-ischaemic encephalopathy under therapeutic hypothermia. |
| Q93010119 | Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model |
| Q48266976 | Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. |
| Q47336486 | Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes |
| Q89757184 | Cell proliferation and neurogenesis alterations in Alzheimer's disease and diabetes mellitus mixed murine models |
| Q35106896 | Central proliferation and neurogenesis is impaired in type 2 diabetes and prediabetes animal models |
| Q46687220 | Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer's disease |
| Q48400715 | Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease |
| Q45262354 | Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. |
| Q38654119 | Cognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn. |
| Q34579152 | Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. |
| Q46396191 | Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. |
| Q44626972 | Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease |
| Q42503800 | Effect of selective cholinergic denervation on the serotonergic system: implications for learning and memory |
| Q45233427 | Evaluation of cholinergic markers in Alzheimer's disease and in a model of cholinergic deficit |
| Q44956213 | Facilitation of cholinergic transmission by combined treatment of ondansetron with flumazenil after cortical cholinergic deafferentation. |
| Q44502847 | Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats |
| Q41700187 | Four-dimensional microglia response to anti-Aβ treatment in APP/PS1xCX3CR1/GFP mice |
| Q44212259 | GABA(A) receptor antagonists enhance cortical acetylcholine release induced by 5-HT(3) receptor blockade in freely moving rats |
| Q101562534 | Germinal Matrix-Intraventricular Hemorrhage of the Preterm Newborn and Preclinical Models: Inflammatory Considerations |
| Q37561154 | Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease |
| Q48616769 | Increased Aβ production prompts the onset of glucose intolerance and insulin resistance. |
| Q36772914 | Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus |
| Q38646201 | Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring |
| Q46558596 | Involvement of an altered 5-HT -{6} receptor function in behavioral symptoms of Alzheimer's disease. |
| Q46582617 | Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease. |
| Q46890582 | Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. |
| Q28575664 | Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release |
| Q38839191 | Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice. |
| Q46618385 | Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes |
| Q44622787 | Low-voltage pattern and absence of sleep-wake cycles are associated with severe hemorrhage and death in very preterm infants. |
| Q39478082 | Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model. |
| Q41230899 | Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice |
| Q30486499 | Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques |
| Q53282362 | Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. |
| Q42722855 | Prediabetes and type 2 diabetes implication in central proliferation and neurogenesis. |
| Q50650694 | Prediabetes-induced vascular alterations exacerbate central pathology in APPswe/PS1dE9 mice. |
| Q53271142 | Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. |
| Q39767994 | Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease |
| Q35689983 | Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease |
| Q42243192 | Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice |
| Q39460000 | Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice |
| Q64990129 | Review of the Effect of Natural Compounds and Extracts on Neurodegeneration in Animal Models of Diabetes Mellitus. |
| Q46940489 | Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease |
| Q35053378 | Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice |
| Q30985447 | Techniques for brain imaging in vivo. |
| Q43098773 | Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease. |
Search more.